ASTRAZENECA AS

Lauren-Jei McCarthy

Director, US Media Relations

Pascal Soriot

Executive Director and CEO

Freja Annamatz

Director, Media Relations, Sweden

Fiona Cookson

Head of US Media Relations

Per Alfredsson

Senior Vice President, Global Biologics Operations; CEO, AstraZeneca AB

Elizabeth Walton

Director of Investor Relations

David Brocklehurst

Vice President, Global Franchise Head, DDR & Gynaecological/Genitourinary Cancers

Dafni Bika

Senior Vice President and Global Head of Pharmaceutical Technology and Development (PT&D), Global Operations

Philip Broadley

Senior independent Non-Executive Director

Ricardo Blanco

Director, Media Relations, Latin America

Jorge Reis-Filho

Chief AI and Data Scientist, Oncology R&D, Astrazeneca

Rodolphe Grepinet

SVP Corporate Development

Matt Hellmann

Vice President, Early Oncology Development, AstraZeneca

Martin Cowie

Vice President Clinical Cardiovascular and Renal Clinical Development, BioPharmaceuticals R&D, AstraZeneca

Kay Tait

Executive Director, Transactions

Iskra Reic

Executive Vice-President, International

Ryan Hicks

Head of Bioscience Cell Therapy, BioPharmaceuticals R&D

Isabel Gibson

Director of Investor Relations

Leora Horn

Global Clinical Head for Lung Cancer and Lung Cancer Strategy

Jeff Pott

Chief Human Resources Officer, Chief Compliance Officer and General Counsel

Peter Schell

Senior Director, Business Development PT&D

Ella Ekholm

Senior Medical Lead, Late-stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Anas Younes

Senior Vice President, Global Head of Haematology (Early and Late Stage) Oncology R&D

Andrew Foxley

Vice President, Franchise Head, Late Oncology R&D

Tatiana Scetinina

Director, Data Science, AstraZeneca

Adam Platt

VP and Head of Translational Science and Experimental Medicine, Respiratory and Immunology, AstraZeneca

Anna Sundgren

Global Development Leader, Lokelma & Bydureon

Louise Pearson

Director of Investor Relations

Shin Morita

Vice President, Oncology Business Unit

Suzanne Cohen

Executive Director and Head of Bioscience Asthma and Skin Immunity, Respiratory and Immunology (R&I), AstraZeneca

Sheri McCoy

Non-Executive Director

Tatiana Kubasova

Business Development Director, Russia & Eurasia

Ratan Bhat

VP and Global Head of Business Development & Licensing, BioPharmaceuticals R&D

Kenny Hansson

Executive Director and Head of Bioscience Cardiovascular, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca

Michele Sample

VP, Late Stage Oncology Clinical Operations, AstraZeneca

Tina Rydén-Bergsten

Global Product Leader, Late-stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Nathan Styles

Executive Director, Head of Search & Evaluation, CVRM, BioPharmaceuticals R&D

Nikhil Muthal

Executive Director, Head of Search & Evaluation, Respiratory & Immunology, BioPharmaceuticals R&D

Sharon Barr

Executive Vice-President, BioPharmaceuticals R&D

Sonny Shergill

Vice President, Commercial Digital Health

Paul Leon, PhD

Senior Director, Business Development, Search & Evaluation, and Partnering

Ruth March

Senior-Vice President of Precision Medicine, R&D Oncology

Marcus Wallenberg

Non-Executive Director

Anne-Claire Gerbaldi

SVP GPPM, Strategic Planning, BDO and Deal Finance

Ken Grime

Executive Director and Head of Bioscience COPD & IPF, Respiratory & Immunology (R&I), AstraZeneca

Nayyar Iqbal

Vice President Clinical Metabolism, BioPharmaceuticals R&D

Gayatri Varma PhD

Executive Director, Head of Transactions, Oncology Business Development

Clive Green

Executive Director and Head of Global Sample Management, Discovery Sciences, R&D

Susan Galbraith

Executive Vice-President, Oncology R&D

Ruud Dobber

Executive Vice-President, BioPharmaceuticals Business Unit

Euan Ashley

Non-Executive Director

Sunil Verma

Senior Vice President, Global Head, Oncology Franchise, AstraZeneca

Birgit Conix

Non-Executive Director

Diana Layfield

Non-Executive Director

Caterina Brindicci

Senior Vice President and Global Head of R&I Late-Stage Development, BioPharmaceuticals R&D, AstraZeneca

Rene Haas

Non-Executive Director

Ben Challis

VP and Head of Translational Science & Experimental Medicine, Cardiovascular, Renal and Metabolism, AstraZeneca

Andy Barnett

Head of Investor Relations

Susanna Myhre

Head of Academic Partnership, BioPharmaceuticals R&D

Christopher Church

Head of Search & Evaluation, Technology, BioPharmaceuticals R&D

David Baker

Executive Director, Head of Bioscience Metabolism, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca

Malin Lemurell

Executive Director and Head of Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D

Lishan Soon

Senior Director, International Communication

Pam Cheng

Executive Vice President, Global Operations, IT & Chief Sustainability Officer

Annette Bak

Head of Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Mark Cobbold

Vice President, Discovery, Oncology R&D

Abhay Kakde

Director, Strategy and Operations, A.Catalyst Network

Eniola Ashafa

PET Lead/Head of Manufacturing for Coppell Supply Site, AstraZeneca

Mark O’Connor

Chief Scientist, Early Oncology Discovery

Polly Brown

VP, Head of Business Development, Oncology R&D

Jim Weatherall

Chief Data Scientist, BioPharmaceuticals R&D, AstraZeneca

Lutz Jermutus

Head of Projects

Ola Engkvist

Associate Director, Computational Chemistry, Discovery Sciences, R&D

Mina Makar

Senior Vice President, Global Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals Business Unit

Shawn Davis

Head of Drug Delivery, BioPharmaceuticals Development, R&D

Judy Campagnari

Executive Director, Head of Alliance and Integration Team (AIT)

Puja Sapra

Senior Vice President, Biologics Engineering & Oncology Targeted Discovery

Richard Yuan

Associate Director, Corporate Development

Ian Kirk

VP, Business Development

Gemma Satterthwaite

Global Product Leader, Oncology Business Unit

David Fredrickson

Executive Vice-President, Oncology Business Unit

Nazneen Rahman

Non-Executive Director

Tonya Villafana

Vice President, Global Franchise Head, Infection

Nipun Jain

Head – Innovation Hubs & Partnerships – International

David Vallo

Head of Alliance Management, BioPharmaceuticals R&D

Francesco Dazzi

Medical Lead Cell Therapies, BioPharmaceuticals R&D, AstraZeneca

Christer Gruvris

Executive Director of Investor Relations

Lauren Swales

Director of Investor Relations

Teresa Klinowska

Global Product Leader, Oncology R&D

Ryan Bate

Senior Director, Strategy & Operations

Regina Fritsche-Danielson

Senior Vice President & Head of Research and Early Development, CVRM, and Gothenburg Site Lead

Philip Sparks

Director of Investor Relations

Anna Manz

Non-Executive Director

Mikhail Kosiborod

Senior Vice President Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca

Tony Mok

Non-Executive Director

Victoria Parker

Executive Group Director, Metabolism, Early Clinical Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca

Sofia Tapani

Head of Early Respiratory & Immunology Statistics, Executive Director Statistics, AstraZeneca

Maurizio Scaltriti

Vice President, Translational Medicine, Early Oncology

Simon Bradford

Data & Analytics Enabling Units Engineering Lead

Tom Keith-Roach

President, AstraZeneca UK

Lisa Hickey

Vice President, US Business Unit Lead Neurology

Marc Howells

Vice President, Talent and Development

Karen Knudsen

Non-Executive Director

Ted Huang

Associate Director, Innovation Hubs & Partnerships Performance

Femi D-Etti

Vice President & General Manager, Mount Vernon Supply, AstraZeneca

Caroline Austin

VP, Head of Transactions UK & Head of PMG Precision Medicine Genomics

Bing Chen

Vice President, International Business Development and Venture Fund

Steve Rees

SVP, Discovery Sciences, R&D

Joris Silon

US Country President, BioPharmaceuticals Business Unit

Aradhana Sarin

Executive Director and Chief Financial Officer

Cassie Gregson

Vice President, R&D IT

Aida Bendt

Head of Alliance Management

Shalini Andersson

Vice President Oligonucleotide Discovery, Discovery Sciences

Brigitte de Lima

Senior Director, Corporate Development

Varun Malhotra

Director, Corporate Development

Marc Dunoyer

Chief Executive Officer, Alexion and Chief Strategy Officer, AstraZeneca

Andrew Christmas

Director of Investor Relations

Madeleine Thun

Senior Director, Alliances and Strategic Partnerships

Bob T. Li

Global Head of Medical Affairs, Oncology, AstraZeneca

Mark T. Esser

Vice President and Head of Microbial Sciences, BioPharmaceuticals R&D

Rasmus Jansson-Löfmark

Executive Director and Head of DMPK, Early CVRM, AstraZeneca

Elisabeth Björk

SVP, Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Ingrid A. Mayer

Global Clinical Head for Breast Cancer and Breast Cancer Strategy

Slavé Petrovski

VP, Centre for Genomics Research, BioPharmaceuticals R&D

Christopher J. Rhodes

Chief Scientist, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, and Chair of AstraZeneca’s postdoc programme

Cristina Durán

Chief Digital Health Officer, R&D

Fredrik Röök

Transaction Director, Business Development Operations

Michel Demaré

Non-Executive Chair of the Board

Nicolas Jose Guzman

Director Physician, Nephrology Clinical Research

Senior Vice President, Biologics Engineering & Oncology Targeted Delivery

Senior Vice President, Biologics Engineering & Oncology Targeted Delivery

Ti Hwei How

Vice President, International Oncology

Gerardo Teja Rivera

Tower Lead for Global Supply Chain & Strategy and External Supply Manufacturing, Guadalajara GITC, AstraZeneca

Janna McCann

Australia & New Zealand Hub Contact

Subhankar Basak

India Hub Contact

Priscilla Peh

Singapore Hub Contact

Gisele Lidia Chamula

South Cone Hub Contact